Cell‐based therapies for amyotrophic lateral sclerosis/motor neuron disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Cell‐based Therapies for Amyotrophic Lateral Sclerosis/motor Neuron Disease." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436235/1/Ketamine_for_management_of_acute_exacerbations_of_asthma_in_children:_Cochrane_systematic_review. Accessed 29 March 2024.
Cell‐based therapies for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436235/1/Ketamine_for_management_of_acute_exacerbations_of_asthma_in_children:_Cochrane_systematic_review. Accessed March 29, 2024.
Cell‐based therapies for amyotrophic lateral sclerosis/motor neuron disease. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/436235/1/Ketamine_for_management_of_acute_exacerbations_of_asthma_in_children:_Cochrane_systematic_review
Cell‐based Therapies for Amyotrophic Lateral Sclerosis/motor Neuron Disease [Internet]. In: Cochrane Abstracts. [cited 2024 March 29]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436235/1/Ketamine_for_management_of_acute_exacerbations_of_asthma_in_children:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Cell‐based therapies for amyotrophic lateral sclerosis/motor neuron disease
ID - 436235
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436235/1/Ketamine_for_management_of_acute_exacerbations_of_asthma_in_children:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -